{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T16:26:46Z","timestamp":1769099206092,"version":"3.49.0"},"reference-count":35,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T00:00:00Z","timestamp":1736985600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background\/Objectives: Previous studies evaluated the prognostic role of hematological parameters in predicting outcome in patients with infective endocarditis (IE). However, only a few studies evaluated the role of hematological parameters in patients undergoing surgery for IE. The aim of this study was to review our 20-year experience with the treatment of native (NVE) and prosthetic (PVE) valve endocarditis and to evaluate the role of neutrophil-to-lymphocyte ratio (NLR), neutrophil-to-platelet ratio (NPR), platelet-to-lymphocyte ratio (PLR), monocyte-to-lymphocyte ratio (MLR), neutrophil-to monocyte ratio (NMR), and systemic inflammatory index (SII) on early and long-term outcomes of patients undergoing surgery for NVE and PVE. Methods: All adult patients undergoing surgery for NVE and PVE at our institution between January 2001 and December 2022 were included in the study. Preoperative NLR, NPR, PLR, MLR, NMR, and SII were calculated using hemograms with complete blood count. Results: During the study period, 503 patients, 371 (74%) males, median age 65 (52\u201373) years, underwent surgery for NVE (n = 337, 67%) or PVE (n = 166, 33%). Patients with PVE had significantly more aortic annulus abscess (95 (57%) vs. 51 (15%); p &lt; 0.001), longer CPB (180 (131\u2013235) vs. 105 (84\u2013145) min; p &lt; 0.001) and aortic cross-clamping times (129 (96\u2013175) vs. 82 (64\u2013114) min; p &lt; 0.001), and received more aortic homografts (47 (28%) vs. 28 (9%); p &lt; 0.001) and postoperative pacemaker implantation (25 (15%) vs. 20 (6%); p &lt; 0.001 compared to patients with NVE. Preoperative NLR was 3.7 (2.4\u20136.1), NPR was 23 (16\u201337), PLR was 159 (106\u2013210), NMR was 8.4 (6.6\u201312), MRL was 0.41 (0.29\u20130.62], and SII was 790 (485\u20131396). NLR, NPR, and MLR were significantly lower in patients with NVE compared to patients with PVE and in survivors compared to non-survivors. Overall mean survival time was 12.2 \u00b1 0.5 years, with patients with NVE having better early and late survival compared to patients with PVE. Patients with preoperative NLR &lt; 3.8, NPR &lt; 30.9, and MLR &lt; 0.4 had significantly better mean survival time compared to patients with preoperative NLR &gt; 3.8, NPR &gt; 30.9, and MLR &gt; 0.4, respectively. Conclusions: In patients undergoing surgery for IE, preoperative higher NLR, NPR, and MLR are associated with increased early and long-term mortality.<\/jats:p>","DOI":"10.3390\/jcm14020533","type":"journal-article","created":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T06:46:10Z","timestamp":1737009970000},"page":"533","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Early and Long-Term Outcomes of Patients Undergoing Surgery for Native and Prosthetic Valve Endocarditis: The Role of Preoperative Neutrophil-to-Lymphocyte Ratio, Neutrophil-to-Platelet Ratio, and Monocyte-to Lymphocyte Ratio"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5965-6571","authenticated-orcid":false,"given":"Antonella","family":"Galeone","sequence":"first","affiliation":[{"name":"Department of Surgery, Dentistry, Pediatrics and Gynecology, Division of Cardiac Surgery, University of Verona, 37126 Verona, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacopo","family":"Gardellini","sequence":"additional","affiliation":[{"name":"Department of Surgery, Dentistry, Pediatrics and Gynecology, Division of Cardiac Surgery, University of Verona, 37126 Verona, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Venanzio","family":"Di Nicola","sequence":"additional","affiliation":[{"name":"Department of Surgery, Dentistry, Pediatrics and Gynecology, Division of Cardiac Surgery, University of Verona, 37126 Verona, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-8290-9406","authenticated-orcid":false,"given":"Fabiola","family":"Perrone","sequence":"additional","affiliation":[{"name":"Department of Surgery, Dentistry, Pediatrics and Gynecology, Division of Cardiac Surgery, University of Verona, 37126 Verona, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Serena","family":"Menzione","sequence":"additional","affiliation":[{"name":"Department of Surgery, Dentistry, Pediatrics and Gynecology, Division of Cardiac Surgery, University of Verona, 37126 Verona, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-1569-0071","authenticated-orcid":false,"given":"Renato","family":"Di Gaetano","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Azienda Sanitaria dell\u2019Alto Adige, 39100 Bolzano, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0931-018X","authenticated-orcid":false,"given":"Giovanni Battista","family":"Luciani","sequence":"additional","affiliation":[{"name":"Department of Surgery, Dentistry, Pediatrics and Gynecology, Division of Cardiac Surgery, University of Verona, 37126 Verona, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,1,16]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"3948","DOI":"10.1093\/eurheartj\/ehad193","article-title":"2023 ESC Guidelines for the management of endocarditis","volume":"44","author":"Delgado","year":"2023","journal-title":"Eur. Heart J."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"17539447211002687","DOI":"10.1177\/17539447211002687","article-title":"Epidemiology of infective endocarditis before versus after change of international guidelines: A systematic review","volume":"15","author":"Williams","year":"2021","journal-title":"Ther. Adv. Cardiovasc. Dis."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.athoracsur.2019.10.029","article-title":"Incidence and Surgical Outcomes of Patients With Native and Prosthetic Aortic Valve Endocarditis","volume":"110","author":"Luehr","year":"2020","journal-title":"Ann. Thorac. Surg."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Galeone, A., Gardellini, J., Trojan, D., Di Nicola, V., Di Gaetano, R., Faggian, G., and Luciani, G.B. (2023). Three Decades of Experience with Aortic Prosthetic Valve Endocarditis. J. Cardiovasc. Dev. Dis., 10.","DOI":"10.3390\/jcdd10080338"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Galeone, A., Gardellini, J., Di Nicola, V., Perrone, F., Boschetti, V., Di Gaetano, R., Onorati, F., and Luciani, G.B. (2023). Twenty-Year Experience with Surgery for Native and Prosthetic Mitral Valve Endocarditis. Medicina, 59.","DOI":"10.3390\/medicina59061060"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.ijcard.2015.09.028","article-title":"A systematic review of biomarkers in the diagnosis of infective endocarditis","volume":"202","author":"Snipsoyr","year":"2016","journal-title":"Int. J. Cardiol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ijid.2020.03.009","article-title":"Biomarkers for prediction of mortality in left-sided infective endocarditis","volume":"96","author":"Siciliano","year":"2020","journal-title":"Int. J. Infect. Dis."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s43044-019-0014-2","article-title":"Neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) as independent predictors of outcome in infective endocarditis (IE)","volume":"71","author":"Meshaal","year":"2019","journal-title":"Egypt Heart J."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"8586418","DOI":"10.1155\/2020\/8586418","article-title":"Neutrophil-Lymphocyte Ratio in Predicting Infective Endocarditis: A Case-Control Retrospective Study","volume":"2020","author":"Chen","year":"2020","journal-title":"Mediat. Inflamm."},{"key":"ref_10","first-page":"58","article-title":"Systemic immune-inflammation index predicts mortality in infective endocarditis","volume":"32","author":"Agus","year":"2020","journal-title":"J. Saudi. Heart Assoc."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1086\/313753","article-title":"Proposed Modifications to the Duke Criteria for the Diagnosis of Infective Endocarditis","volume":"30","author":"Li","year":"2000","journal-title":"Clin. Infect. Dis."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"VARC-3 WRITING COMMITTEE, G\u00e9n\u00e9reux, P., Piazza, N., Alu, M.C., Nazif, T., Hahn, R.T., Pibarot, P., Bax, J.J., Leipsic, J.A., and Blanke, P. (2021). Valve Academic Research Consortium 3: Updated Endpoint Definitions for Aortic Valve Clinical Research. J. Am. Coll. Cardiol., 77, 2717\u20132746.","DOI":"10.1016\/j.jacc.2021.02.038"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/S0140-6736(02)08272-7","article-title":"Quantification of the completeness of follow-up","volume":"359","author":"Clark","year":"2002","journal-title":"Lancet"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Chen, H., Zhan, Y., Zhang, K., Gao, Y., Chen, L., Zhan, J., Chen, Z., and Zeng, Z. (2022). The Global, Regional, and National Burden and Trends of Infective Endocarditis from 1990 to 2019: Results from the Global Burden of Disease Study 2019. Front. Med., 9.","DOI":"10.3389\/fmed.2022.774224"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.jtcvs.2006.08.060","article-title":"Surgical treatment of active infective endocarditis: A continued challenge","volume":"133","author":"David","year":"2007","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"ref_16","first-page":"508","article-title":"Early outcome after surgery for active native and prosthetic aortic valve endocarditis","volume":"17","author":"Gabbieri","year":"2008","journal-title":"J. Heart Valve Dis."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.athoracsur.2011.10.063","article-title":"Outcomes after surgical treatment of native and prosthetic valve infective endocarditis","volume":"93","author":"Manne","year":"2012","journal-title":"Ann. Thorac. Surg."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1093\/ejcts\/ezu281","article-title":"Surgical management of infective endocarditis: An analysis of early and late outcomes","volume":"47","author":"Pang","year":"2015","journal-title":"Eur. J. Cardiothorac. Surg."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Scheggi, V., Merilli, I., Marcucci, R., Del Pace, S., Olivotto, I., Zoppetti, N., Ceschia, N., Andrei, V., Alterini, B., and Stef\u00e0no, P.L. (2021). Predictors of mortality and adverse events in patients with infective endocarditis: A retrospective real world study in a surgical centre. BMC Cardiovasc. Disord., 21.","DOI":"10.1186\/s12872-021-01853-6"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"ezac193","DOI":"10.1093\/ejcts\/ezac193","article-title":"Cryopreserved aortic homografts for complex aortic valve or root endocarditis: A 28-year experience","volume":"62","author":"Galeone","year":"2022","journal-title":"Eur. J. Cardiothorac. Surg."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.ajem.2019.10.023","article-title":"Prognostic value of neutrophil-to-lymphocyte ratio in sepsis: A meta-analysis","volume":"38","author":"Huang","year":"2020","journal-title":"Am. J. Emerg. Med."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Mosca, M., Nigro, M.C., Pagani, R., De Giglio, A., and Di Federico, A. (2023). Neutrophil-to-Lymphocyte Ratio (NLR) in NSCLC, Gastrointestinal, and Other Solid Tumors: Immunotherapy and Beyond. Biomolecules, 13.","DOI":"10.3390\/biom13121803"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Angkananard, T., Anothaisintawee, T., McEvoy, M., Attia, J., and Thakkinstian, A. (2018). Neutrophil Lymphocyte Ratio and Cardiovascular Disease Risk: A Systematic Review and Meta-Analysis. Biomed. Res. Int., 2018.","DOI":"10.1155\/2018\/2703518"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Zhai, G., Wang, J., Liu, Y., and Zhou, Y. (2021). Platelet-lymphocyte ratio as a new predictor of in-hospital mortality in cardiac intensive care unit patients. Sci. Rep., 11.","DOI":"10.1038\/s41598-021-02686-1"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"107736","DOI":"10.1016\/j.intimp.2021.107736","article-title":"Association of monocyte-lymphocyte ratio with in-hospital mortality in cardiac intensive care unit patients","volume":"96","author":"Zhai","year":"2021","journal-title":"Int. Immunopharmacol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1016\/j.cjca.2013.05.005","article-title":"Usefulness of neutrophilto-lymphocyte ratio to predict in-hospital outcomes in infective endocarditis","volume":"29","author":"Turak","year":"2013","journal-title":"Can. J. Cardiol."},{"key":"ref_27","first-page":"617","article-title":"Neutrophil-to-lymphocyte ratio as a prognostic marker in infective endocarditis: Inhospital and long-term clinical results","volume":"23","author":"Bozbay","year":"2014","journal-title":"J. Heart Valve Dis."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Polewczyk, M., Jache\u0107, W., Szcz\u0119\u015bniak-Sta\u0144czyk, D., Polewczyk, A., Tomaszewski, A., Brzozowski, W., Nowosielecka, D., and Kutarski, A. (2023). Novel Hematological Parameters in the Assessment of the Extent of Cardiac Implantable Electronic Device-Related Infections. J. Clin. Med., 12.","DOI":"10.20944\/preprints202311.0422.v1"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.amjcard.2015.01.021","article-title":"Usefulness of thrombocytopenia at admission as a prognostic marker in native valve left-sided infective endocarditis","volume":"115","author":"Ferrera","year":"2015","journal-title":"Am. J. Cardiol."},{"key":"ref_30","first-page":"1053","article-title":"Incidence and predictors of postoperative need for high-dose inotropic support in patients undergoing cardiac surgery for infective endocarditis","volume":"17","author":"Belletti","year":"2017","journal-title":"J. Cardiothorac. Vasc. Anesth."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.ihj.2023.10.008","article-title":"Comparison of neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and systemic immune-inflammation index (SII) as marker of adverse prognosis in patients with infective endocarditis","volume":"75","author":"Thottuvelil","year":"2023","journal-title":"Indian Heart J."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1186\/s12935-020-01590-4","article-title":"Prognostic value of systemic immune-inflammation index in patients with urologic cancers: A meta-analysis","volume":"20","author":"Huang","year":"2020","journal-title":"Cancer Cell Int."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1186\/s40001-023-01529-1","article-title":"Systemic immune-inflammation index (SII) and the risk of all-cause, cardiovascular, and cardio-cerebrovascular mortality in the general population","volume":"28","author":"Wang","year":"2023","journal-title":"Eur. J. Med. Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1536\/ihj.21-627","article-title":"Systemic immune-inflammation index predicts embolic events in infective endocarditis","volume":"63","author":"Hu","year":"2022","journal-title":"Int. Heart J."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"5497","DOI":"10.1097\/MS9.0000000000001249","article-title":"Novel putative biomarkers for infective endocarditis by serum proteomic analysis: A comprehensive review of literature","volume":"85","author":"Begum","year":"2023","journal-title":"Ann. Med. Surg."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/2\/533\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T10:29:34Z","timestamp":1759919374000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/2\/533"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,16]]},"references-count":35,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,1]]}},"alternative-id":["jcm14020533"],"URL":"https:\/\/doi.org\/10.3390\/jcm14020533","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,16]]}}}